|Day's Range||0.23 - 0.25|
|52 Week Range||0.15 - 0.50|
|PE Ratio (TTM)||-2.53|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo Finance Get free summary analysis Pressure BioSciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Pressure BioSciences, Inc. – MOCON, Inc., PerkinElmer, Inc., Harvard Bioscience, Inc., Thermo Fisher Scientific Inc. and Bruker Corporation (MOCO-US, PKI-US, HBIO-US, TMO-US and BRKR-US) that have also reported ... Read more (Read more...)
“In a research lab, one of the most critical parts of scientific research is what we call sample preparation. It is absolutely critical that you are as good as you can be when you’re preparing the sample ...
The company expects grant revenue to begin to increase in the fourth quarter of 2016 and continue to increase into 2017. Total revenue decreased to $535,334 in the third quarter 2016 from $580,334 for the third quarter of 2015. Adjusted net loss per common share was $(0.02) for the quarters ended September 30, 2016, compared to net loss per share of (0.03) for third quarter of 2015.